转自：贝壳财经 调价的同时，不少黄金品牌如老铺黄金、周大福等推出了"满1000-100"、"克减优惠"、"工费折扣"等活 动。或因调价和活动刺激，国内多地出现买金热潮。以老铺黄金为例，部分门店不到上午9点已经无号 可取，有网友反馈排队时间超8个小时。 金价一路飙升至1500元，哪些人还在抢购黄金呢？有水贝商家透露，春节期间购买三金、五金的客人占 了多数。22日，#结婚五金起步价迈入10万元大关# 冲上热搜。有商家表示，现在五金至少10万起，小 克重金饰销量更好。 实际上，春节本就是黄金消费的传统旺季，婚嫁、赠礼等刚性需求集中释放。此外罗湖发布披露的数据 显示，旧换新业务同比增长超50%，成为拉动消费增长的核心动力。@蓝鲸新闻 【#春节买金热有金店排队8小时#】#哪些人在春节排队买金# 在经历一段时间的高位波动后，现货黄金价格重回5100美元/盎司，国内多家品牌足金饰品报价随之涨 至1500元上方。据蓝鲸记者不完全统计，多家黄金品牌已在2025年普遍涨价2-4次。 ...

2月18日，老铺黄金发布调价通知，将于2026年2月28日进行产品价格调整。产品调价详情，以线上线下 产品实际标价为准。据了解，老铺黄金每年有2-3次调价。2025年，老铺黄金于2月、8月、10月三次上 调售价。 ...

经济观察网 健麾信息近期完成对博科国信38%股权的收购，实现对后者的控股，并披露其募投项目延 期至2027年2月。 经济观察网 健麾信息近期完成对博科国信38%股权的收购，实现对后者的控股，并披露其募投项目延 期至2027年2月。 公司项目推进 2026年2月5日，公司公告拟以7371.02万元收购博科国信（武汉）科技有限公司38%股权，交易完成后 持股比例从32%提升至70%，标的公司将成为控股子公司并纳入合并报表。本次收购基于标的公司2025 年度净利润1433万元，按13.54倍市盈率定价，并设置了2026年至2028年的业绩承诺条款，旨在整合医 疗信息化能力，加速海外市场拓展和"软硬件+AI"业务协同。 项目进展 公司项目推进 2026年2月5日，公司公告拟以7371.02万元收购博科国信（武汉）科技有限公司38%股权，交易完成后 持股比例从32%提升至70%，标的公司将成为控股子公司并纳入合并报表。本次收购基于标的公司2025 年度净利润1433万元，按13.54倍市盈率定价，并设置了2026年至2028年的业绩承诺条款，旨在整合医 疗信息化能力，加速海外市场拓展和"软硬件+AI"业务协同。 项目进 ...

来源：环球网 【环球网消费综合报道】"中国文化太惊艳了"、"她总能在对的时间，把美好的东方礼物带回美国。" 74岁国际名模梅耶·马斯克在海外社交平台上发布的一段视频，引发数千海外网友留言围观，感慨东方 审美正在征服全球。 在这段两分多钟的视频，梅耶·马斯克记录了前不久在中国上海到老铺黄金的购物经历。"惊艳、优雅且 新颖"、 "工艺如此精美，工匠一定极富才华。" 老铺黄金的金器、金饰作品让这位国际名模连连赞叹， 她最终买下一款象征着自由和重生的蝴蝶吊坠送给自己，还选择了一款具有福禄寓意的葫芦送给家人作 为新春礼物。 看过视频，不少外国网友被中国文化和非遗工艺震撼。"一件作品需要十几万次捶打，这就是对现在美 国制造最优雅的反叛！""被东方审美的高级震撼了，希望这样的品牌能来纽约开店"。甚至连她的安哥 拉名模好友Maria Borges也被惊艳到，前来围观互动。 2025年，老铺黄金现象级的人气，持续引发全球关注。在最新《2026胡润至尚优品报告》里，老铺黄金 直接冲进"高净值人群最青睐的世界珠宝品牌前三"，而且是唯一上榜的中国品牌。 历峰集团CEO Nicolas Bos此前公开表示，老铺黄金植根于中国文化，推动 ...

Transaction Overview - The company plans to acquire 38% equity of Boke Guoxin (Wuhan) Technology Co., Ltd. for a total consideration of RMB 73.71 million, distributed among four sellers [2][4][17] - After the transaction, the company's ownership in the target company will increase from 32% to 70%, making it a subsidiary included in the consolidated financial statements [2][4][36] - This acquisition is a strategic move to enhance the company's capabilities in automation hardware, software platforms, and medical AI applications, promoting a comprehensive integration of products and solutions [4][5][35] Financial Details - The target company achieved an unaudited net profit of RMB 14.33 million in 2025, leading to an overall valuation of RMB 194 million based on a price-to-earnings (PE) ratio of 13.54 [12][15] - The acquisition price reflects a significant premium over the target company's net assets, with a net asset appreciation rate of 200.13% [15][36] Strategic Implications - The acquisition is expected to enhance the company's market competitiveness by integrating its existing products with the target company's AI solutions, thereby creating a more comprehensive smart hospital solution [5][35] - The target company is a member of the China Healthcare Information Interoperability Technology Alliance and has experience with international healthcare standards, which will aid in expanding the company's overseas market presence [5][35] Approval and Compliance - The transaction was approved by the company's board on February 5, 2026, and does not require shareholder approval as it does not constitute a related party transaction or a major asset restructuring [3][6][35] - The transaction is subject to various regulatory approvals and the signing of a share transfer agreement, which has not yet occurred [3][6][35] Management and Operational Changes - Post-acquisition, the target company's board will be restructured, with the company's representatives holding a majority of the board seats, and the chairman will be the company's actual controller [37][36] - The transaction does not involve any personnel changes or land leasing issues within the target company [37][36]

Mergers and Acquisitions - Jianhui Information plans to acquire 38% equity of Boke Guoxin (Wuhan) Technology Co., Ltd. for RMB 73.71 million, increasing its stake from 32% to 70%, making it a controlling subsidiary [1] - Tianqimo is planning to acquire equity in Dongshi Automotive Technology Group Co., Ltd. through a combination of issuing shares and cash payments, while also raising supporting funds [2] - Jiangfeng Electronics intends to acquire 15.64% of Kaide Quartz for RMB 448 million, with related parties also purchasing shares, resulting in Jiangfeng becoming the controlling shareholder [3] Shareholding Changes - Beijia Clean has multiple shareholders planning to reduce their holdings by a total of up to 2.9926%, with specific reductions from various entities [4] - Kangpeng Technology announced that shareholders plan to collectively reduce their holdings by up to 5.22%, with specific amounts and percentages detailed for each shareholder [5] - Xianheng International reported that several shareholders intend to reduce their holdings by up to 3%, totaling 1,228,180 shares [6] Risk Matters - *ST Zhengping received a regulatory letter from the Shanghai Stock Exchange regarding its 2025 performance forecast, indicating expected revenue over RMB 300 million but a net loss, with concerns raised by the annual auditor [7] - Beiqing Song's actual controller, Ma Xuejun, is under investigation for alleged market manipulation, although it is stated that this will not significantly impact the company's daily operations [8][9] - *ST Lifang announced a risk of rapid stock price decline and will suspend trading for verification, marking its third suspension this year, with a recent closing price of RMB 2.78 and a market cap of approximately RMB 1.8 billion [10]

Group 1 - Company X is currently undergoing auditing and evaluation work [1] - Company Y has not yet received any orders in the "space photovoltaic" sector [1] - Company Z plans to invest 1 billion yuan in the construction of a synthetic biology manufacturing project in Xinjiang [1] Group 2 - Company A has won a 994 million yuan EPC project [1] - Company B's subsidiary has secured a project worth 101 million yuan [1] - Company C's subsidiary is expected to be awarded a project for the total engineering contract of Huahong FAB9B [1] Group 3 - Company D reported a net profit of 177 million yuan for 2025, representing a year-on-year increase of 42.81% [1] - Company E reported a net profit of 34.93 million yuan for 2025, with a year-on-year growth of 30.13% [1] Group 4 - Company F plans to acquire a portion of equity in Company G, which will increase its holding and achieve control [1] - Company H and its subsidiary plan to transfer 80% of the equity in Wuhan Shengchong [1] Group 5 - Company I has completed the repurchase of 875,000 shares [2] - Company J plans to raise no more than 5 billion yuan through a private placement for a 20GWh power battery project [2] - Company K's actual controller is under investigation by the China Securities Regulatory Commission for alleged market manipulation [2]

（文章来源：证券日报） 证券日报网讯 2月5日，健麾信息发布公告称，公司拟以3768.75万元、2285.63万元、637.50万元、 679.14万元分别收购周校平、泽朴投资、博科医信、博科国信持有的博科国信（武汉）科技有限公司 16.75%、13.25%、4.00%、4.00%股权，交易完成后公司将持有标的公司70%股权，标的公司将成为公 司控股子公司并纳入合并报表。 ...

Core Viewpoint - The company, Jianhui Information, plans to acquire additional equity in Boke Guoxin (Wuhan) Technology Co., Ltd., increasing its ownership from 32% to 70%, thereby making it a subsidiary and consolidating it into the company's financial statements [1] Group 1: Acquisition Details - Jianhui Information will purchase 16.75%, 13.25%, 4%, and 4% equity stakes from four entities for a total of 37.687 million yuan [1] - Post-transaction, the remaining 30% of Boke Guoxin will be held by Zhou Xiaoping [1] Group 2: Strategic Implications - This acquisition is a key move for the company to implement its intelligent development strategy and enhance industry chain collaboration [1] - The increased stake will allow for better integration of technology advantages in automation hardware, software platforms, and medical AI [1] - The collaboration aims to create a more competitive overall solution for smart hospitals and regional healthcare [1]

公告编号:2026-003 （来源：财闻） 标的公司是中国医疗卫生信息互联互通技术联盟暨HL7 China的会员单位，是中部地区首家通过FHIR Connectathon 13项系统测试的医疗信息化企业。 2月5日，健麾信息（605186.SH）公告称，公司拟以3768.75万元、2285.63万元、637.50万元、679.14万 元分别收购周校平、泽朴投资、博科医信、博科国信持有的博科国信（武汉）科技有限公司16.75%、 13.25%、4.00%、4.00%股权。交易完成后，健麾信息将持有标的公司70%的股权。 标的公司是中国医疗卫生信息互联互通技术联盟暨HL7 China的会员单位，是中部地区首家通过FHIR Connectathon 13项系统测试的医疗信息化企业。标的公司在医疗AI应用（如B-Klinik智能体）方面的研 发积累，将为公司核心业务注入智能化创新动能，有助于开拓在智慧医院、县域医共体及数智康养等领 域的业务机会。 证券代码:605186 证券简称:健磨信息 ● 交易简要内容 上海健麾信息技术股份有限公司(以下简称"公司"或"健磨信息") 拟以人民币 3,768.75 万元、2,285 ...